Occurrence of tetracycline resistance genes among Escherichia coli isolates from the phase 3 clinical trials for tigecycline
- PMID: 17620376
- PMCID: PMC2043223
- DOI: 10.1128/AAC.00625-07
Occurrence of tetracycline resistance genes among Escherichia coli isolates from the phase 3 clinical trials for tigecycline
Abstract
Tigecycline, a member of the glycylcycline class of antibiotics, was designed to maintain the antibacterial spectrum of the tetracyclines while overcoming the classic mechanisms of tetracycline resistance. The current study was designed to monitor the prevalence of the tet(A), tet(B), tet(C), tet(D), tet(E), and tet(M) resistance determinants in Escherichia coli isolates collected during the worldwide tigecycline phase 3 clinical trials. A subset of strains were also screened for the tet(G), tet(K), tet(L), and tet(Y) genes. Of the 1,680 E. coli clinical isolates screened for resistance to classical tetracyclines, 405 (24%) were minocycline resistant (MIC > or = 8 microg/ml) and 248 (15%) were tetracycline resistant (MIC > or = 8 microg/ml) but susceptible to minocycline (MIC < or = 4 microg/ml). A total of 452 tetracycline-resistant, nonduplicate isolates were positive by PCR for at least one of the six tetracycline resistance determinants examined. Over half of the isolates encoding a single determinant were positive for tet(A) (26%) or tet(B) (32%) with tet(C), tet(D), tet(E), and tet(M), collectively, found in 4% of isolates. Approximately 33% of the isolates were positive for more than one resistance determinant, with the tet(B) plus tet(E) combination the most highly represented, found in 11% of isolates. The susceptibilities of the tetracycline-resistant strains to tigecycline (MIC(90), 0.5 microg/ml), regardless of the encoded tet determinant(s), were comparable to the tigecycline susceptibility of tetracycline-susceptible strains (MIC(90), 0.5 microg/ml). The results provide a current (2002 to 2006) picture of the distribution of common tetracycline resistance determinants encoded in a globally sourced collection of clinical E. coli strains.
Figures

Similar articles
-
In vitro and in vivo antibacterial activities of a novel glycylcycline, the 9-t-butylglycylamido derivative of minocycline (GAR-936).Antimicrob Agents Chemother. 1999 Apr;43(4):738-44. doi: 10.1128/AAC.43.4.738. Antimicrob Agents Chemother. 1999. PMID: 10103174 Free PMC article.
-
Diagnostic PCR analysis of the occurrence of methicillin and tetracycline resistance genes among Staphylococcus aureus isolates from phase 3 clinical trials of tigecycline for complicated skin and skin structure infections.Antimicrob Agents Chemother. 2006 Feb;50(2):505-10. doi: 10.1128/AAC.50.2.505-510.2006. Antimicrob Agents Chemother. 2006. PMID: 16436703 Free PMC article.
-
Effects of efflux transporter genes on susceptibility of Escherichia coli to tigecycline (GAR-936).Antimicrob Agents Chemother. 2004 Jun;48(6):2179-84. doi: 10.1128/AAC.48.6.2179-2184.2004. Antimicrob Agents Chemother. 2004. PMID: 15155219 Free PMC article.
-
Other antimicrobials of interest in the era of extended-spectrum beta-lactamases: fosfomycin, nitrofurantoin and tigecycline.Clin Microbiol Infect. 2008 Jan;14 Suppl 1:198-202. doi: 10.1111/j.1469-0691.2007.01852.x. Clin Microbiol Infect. 2008. PMID: 18154548 Review.
-
Tigecycline: in-vitro performance as a predictor of clinical efficacy.Clin Microbiol Infect. 2007 Apr;13(4):354-62. doi: 10.1111/j.1469-0691.2006.01621.x. Clin Microbiol Infect. 2007. PMID: 17359318 Review.
Cited by
-
Antimicrobial resistance and prevalence of tetracycline resistance genes in Escherichia coli isolated from lesions of colibacillosis in broiler chickens in Sistan, Iran.BMC Vet Res. 2020 Aug 3;16(1):267. doi: 10.1186/s12917-020-02488-z. BMC Vet Res. 2020. PMID: 32746815 Free PMC article.
-
Prevalence of Antimicrobial Resistance and Transfer of Tetracycline Resistance Genes in Escherichia coli Isolates from Beef Cattle.Appl Environ Microbiol. 2015 Aug 15;81(16):5560-6. doi: 10.1128/AEM.01511-15. Epub 2015 Jun 5. Appl Environ Microbiol. 2015. PMID: 26048929 Free PMC article.
-
Low levels of tetracyclines select for a mutation that prevents the evolution of high-level resistance to tigecycline.PLoS Biol. 2022 Sep 28;20(9):e3001808. doi: 10.1371/journal.pbio.3001808. eCollection 2022 Sep. PLoS Biol. 2022. PMID: 36170241 Free PMC article.
-
Tigecycline for the treatment of multidrug-resistant Enterobacteriaceae: a systematic review of the evidence from microbiological and clinical studies.J Antimicrob Chemother. 2008 Nov;62(5):895-904. doi: 10.1093/jac/dkn311. Epub 2008 Aug 1. J Antimicrob Chemother. 2008. PMID: 18676620 Free PMC article.
-
Multidrug-resistant gram-negative bacteria colonization of healthy US military personnel in the US and Afghanistan.BMC Infect Dis. 2013 Feb 5;13:68. doi: 10.1186/1471-2334-13-68. BMC Infect Dis. 2013. PMID: 23384348 Free PMC article.
References
-
- Akiba, T., K. Koyama, Y. Ishiki, S. Kimura, and T. Fukushima. 1960. On the mechanism of the development of multiple-drug-resistant clones of Shigella. Jpn. J. Microbiol. 4:219-227. - PubMed
-
- Babinchak, T., E. J. Ellis-Grosse, N. Dartois, G. M. Rose, and E. G. Loh. 2005. The efficacy and safety of tigecycline in the treatment of complicated intra-abdominal infections: analysis of pooled clinical trial data. Clin. Infect. Dis. 41:S354-S367. - PubMed
-
- Bauer, G., C. Berens, S. J. Projan, and W. Hillen. 2004. Comparison of tetracycline and tigecycline binding to ribosomes mapped by dimethylsulphate and drug-directed Fe2+ cleavage of 16S rRNA. J. Antimicrob. Chemother. 53:592-599. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical